Ruizheng Shi

894 total citations
44 papers, 645 citations indexed

About

Ruizheng Shi is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Immunology. According to data from OpenAlex, Ruizheng Shi has authored 44 papers receiving a total of 645 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Cardiology and Cardiovascular Medicine, 14 papers in Molecular Biology and 8 papers in Immunology. Recurrent topics in Ruizheng Shi's work include Cardiovascular Disease and Adiposity (4 papers), Eicosanoids and Hypertension Pharmacology (4 papers) and Heart Failure Treatment and Management (4 papers). Ruizheng Shi is often cited by papers focused on Cardiovascular Disease and Adiposity (4 papers), Eicosanoids and Hypertension Pharmacology (4 papers) and Heart Failure Treatment and Management (4 papers). Ruizheng Shi collaborates with scholars based in China, United States and Hong Kong. Ruizheng Shi's co-authors include Zhaoya Liu, Guogang Zhang, Yuan‐Jian Li, Liao Tan, Qian Xu, Chan Li, Yongping Bai, Tianlun Yang, Xingxuan He and Wei Pan and has published in prestigious journals such as PLoS ONE, Scientific Reports and Biochemical and Biophysical Research Communications.

In The Last Decade

Ruizheng Shi

42 papers receiving 639 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ruizheng Shi China 15 308 140 104 91 84 44 645
Bingqing Deng China 15 306 1.0× 156 1.1× 71 0.7× 79 0.9× 86 1.0× 42 642
Liang Xie United States 13 248 0.8× 116 0.8× 108 1.0× 45 0.5× 84 1.0× 20 568
Jen‐Fang Cheng Taiwan 8 230 0.7× 146 1.0× 163 1.6× 63 0.7× 45 0.5× 20 567
Zeqi Zheng China 17 381 1.2× 191 1.4× 53 0.5× 102 1.1× 89 1.1× 48 786
Katina M. Wilson United States 13 251 0.8× 177 1.3× 122 1.2× 78 0.9× 59 0.7× 18 811
Sung Kwang Park South Korea 11 417 1.4× 143 1.0× 101 1.0× 87 1.0× 88 1.0× 22 861
Tatiana Novitskaya United States 14 334 1.1× 66 0.5× 123 1.2× 91 1.0× 158 1.9× 25 772
Chunpeng Zou China 14 310 1.0× 211 1.5× 56 0.5× 100 1.1× 81 1.0× 35 799
Bambang Widyantoro Indonesia 8 233 0.8× 280 2.0× 135 1.3× 112 1.2× 49 0.6× 36 636
Xiangquan Kong China 15 179 0.6× 119 0.8× 69 0.7× 77 0.8× 56 0.7× 36 546

Countries citing papers authored by Ruizheng Shi

Since Specialization
Citations

This map shows the geographic impact of Ruizheng Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruizheng Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruizheng Shi more than expected).

Fields of papers citing papers by Ruizheng Shi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruizheng Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruizheng Shi. The network helps show where Ruizheng Shi may publish in the future.

Co-authorship network of co-authors of Ruizheng Shi

This figure shows the co-authorship network connecting the top 25 collaborators of Ruizheng Shi. A scholar is included among the top collaborators of Ruizheng Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruizheng Shi. Ruizheng Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sun, Deheng, Xin Cai, Xiao Ding, et al.. (2025). Design, Synthesis and Biological Evaluation of Novel, Potent, Selective and Orally Available DGKα Inhibitors for the Treatment of Tumors. Journal of Medicinal Chemistry. 68(23). 25011–25025.
2.
Niu, Hongya, et al.. (2025). Characterization of PM2.5-borne heavy metal pollution from industrial sources and human health risk assessment. Atmospheric Environment. 353. 121254–121254. 1 indexed citations
3.
Liao, Zhifang, Yuanzhe Li, Qingquan Lai, et al.. (2023). Placental MRI segmentation based on multi-receptive field and mixed attention separation mechanism. Computer Methods and Programs in Biomedicine. 242. 107699–107699. 3 indexed citations
4.
Tan, Liao, Yubo Liu, Jie Liu, Zhaoya Liu, & Ruizheng Shi. (2023). Associations of individual and mixture exposure to volatile organic compounds with metabolic syndrome and its components among US adults. Chemosphere. 347. 140683–140683. 11 indexed citations
5.
Zhao, Min, Baiyang You, Xiaole Wang, et al.. (2023). Desipramine enhances the stability of atherosclerotic plaque in rabbits monitored with molecular imaging. PLoS ONE. 18(3). e0283612–e0283612. 3 indexed citations
6.
Liu, Jie, Liao Tan, Zhaoya Liu, & Ruizheng Shi. (2022). The association between non-alcoholic fatty liver disease (NAFLD) and advanced fibrosis with blood selenium level based on the NHANES 2017-2018. Annals of Medicine. 54(1). 2258–2267. 23 indexed citations
7.
Liu, Jie, Liao Tan, Zhaoya Liu, & Ruizheng Shi. (2022). Blood and urine manganese exposure in non-alcoholic fatty liver disease and advanced liver fibrosis: an observational study. Environmental Science and Pollution Research. 30(9). 22222–22231. 7 indexed citations
8.
Gu, Xiaoyu, et al.. (2022). COVID-19 is associated with the risk of cardiovascular disease death: A two-sample Mendelian randomization study. Frontiers in Cardiovascular Medicine. 9. 974944–974944. 8 indexed citations
9.
Tan, Liao, Qian Xu, & Ruizheng Shi. (2021). A Nomogram for Predicting Hospital Mortality in Intensive Care Unit Patients with Acute Myocardial Infarction. International Journal of General Medicine. Volume 14. 5863–5877. 15 indexed citations
10.
Cao, Jing, Guogang Zhang, Zhaoya Liu, et al.. (2021). Peroxidasin promotes diabetic vascular endothelial dysfunction induced by advanced glycation end products via NOX2/HOCl/Akt/eNOS pathway. Redox Biology. 45. 102031–102031. 31 indexed citations
11.
Cao, Jing, Zhaoya Liu, Jie Liu, et al.. (2021). Bioinformatics Analysis and Identification of Genes and Pathways in Ischemic Cardiomyopathy. International Journal of General Medicine. Volume 14. 5927–5937. 16 indexed citations
12.
Li, Chan, Zeyu Zhang, Qian Xu, & Ruizheng Shi. (2020). Comprehensive Analyses of miRNA‐mRNA Network and Potential Drugs in Idiopathic Pulmonary Arterial Hypertension. BioMed Research International. 2020(1). 5156304–5156304. 11 indexed citations
13.
Liu, Zhaoya, Qian Xu, Jing Cao, et al.. (2019). Vascular peroxidase 1 is a novel regulator of cardiac fibrosis after myocardial infarction. Redox Biology. 22. 101151–101151. 38 indexed citations
14.
Shi, Ruizheng, et al.. (2015). Progress of EGFR-TKI and ALK/ROS1 inhibitors in advanced non-small cell lung cancer.. PubMed. 8(7). 10330–9. 20 indexed citations
15.
Chen, Xiaoping, et al.. (2014). Involvement of Anandamide Transporter in Calcitonin Gene-related Peptide Expression Stimulated by Nitroglycerin and Influence of ALDH2 Glu504Lys Polymorphism. Journal of Cardiovascular Pharmacology. 64(5). 460–464. 3 indexed citations
16.
Li, Shujun, Ruizheng Shi, Yongping Bai, et al.. (2013). Targeted introduction of tissue plasminogen activator (TPA) at the AAVS1 locus in mesenchymal stem cells (MSCs) and its stable and effective expression. Biochemical and Biophysical Research Communications. 437(1). 74–78. 4 indexed citations
17.
Chen, Meifang, Yuan‐Jian Li, Yongjin Wang, et al.. (2011). Involvement of profilin-1 in angiotensin II-induced vascular smooth muscle cell proliferation. Vascular Pharmacology. 55(1-3). 34–41. 26 indexed citations
18.
Li, Xiaohui, Jun Peng, Na Tan, et al.. (2010). Involvement of asymmetric dimethylarginine and Rho kinase in the vascular remodeling in monocrotaline-induced pulmonary hypertension. Vascular Pharmacology. 53(5-6). 223–229. 29 indexed citations
19.
Chen, Min, Xiaoping Chen, Yijie Guo, Ruizheng Shi, & Guogang Zhang. (2010). Brain natriuretic peptide rs198388 polymorphism and essential hypertension in Hunan Han people.. PubMed. 35(12). 1207–13. 8 indexed citations
20.
Chen, An, Xiaoping Chen, Ruizheng Shi, et al.. (2009). [Association of genetic polymorphism in phenylethanolamine-N-methyl transferase with essential hypertension in Changsha Han people].. PubMed. 34(11). 1120–5. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bingqing Deng Breakdown of academic impact, for papers by Liang Xie Breakdown of academic impact, for papers by Jen‐Fang Cheng Breakdown of academic impact, for papers by Zeqi Zheng Breakdown of academic impact, for papers by Katina M. Wilson Breakdown of academic impact, for papers by Sung Kwang Park Breakdown of academic impact, for papers by Tatiana Novitskaya Breakdown of academic impact, for papers by Chunpeng Zou Breakdown of academic impact, for papers by Bambang Widyantoro Breakdown of academic impact, for papers by Xiangquan Kong
Rankless by CCL
2026